Evaluation of an agonist index: Affinity ratio for compounds active on muscarinic cholinergic M2 receptors

Journal of Autonomic Pharmacology

Volumn 19, Issue 2, 1999, Pages 77-84

  Tayebati, S K ^a   Piergentili, A ^a   Natale, D ^a   Amenta, F ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

[4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; AG 11; AG 20; ATROPINE; BRAIN RECEPTOR; HEART RECEPTOR; METHYLSCOPOLAMINE; MUSCARINE; MUSCARINIC M2 RECEPTOR AGONIST; MUSCARINIC M2 RECEPTOR ANTAGONIST; OXOTREMORINE; OXOTREMORINE M; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FRONTAL CORTEX; GUINEA PIG; HEART; ILEUM; MALE; NONHUMAN; RADIOASSAY; RAT; RECEPTOR AFFINITY;

ANIMALS; BINDING, COMPETITIVE; CEREBRAL CORTEX; GUINEA PIGS; ILEUM; ISOMETRIC CONTRACTION; MALE; MUSCLE, SMOOTH; MYOCARDIUM; N-METHYLSCOPOLAMINE; OXOTREMORINE; RABBITS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MUSCARINIC; SUBMANDIBULAR GLAND; URINARY BLADDER; VAS DEFERENS; VISUAL CORTEX;

EID: 0032790238     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2680.1999.00118.x     Document Type: Article

References (30)

1. ADACHI, S., KOIKE, K. & TAKAYANAGI, I. (1996). Pharmacological characteristics of indoline derivatives in muscarinic receptor subtypes. Pharmacology, 53, 250-258.
2. BARNES, P.J. (1992). Modulation of neurotransmission in airways. Physiol. Rev., 72, 699-729.
3. BARNES, P.J. (1993). Muscarinic receptor subtypes in airways. Life Sci., 52, 521-527.
4. BIRDSALL, N.J.M., BURGEN, A.S.V. & HUME, E.C. (1978). The binding of agonists to brain muscarinic receptors. Mol. Pharmacol., 14, 723-736.
5. BIRDSALL, N.J.M., HULME, E.C. & BURGEN, A.S.V. (1980). The character of the muscarinic receptors in different regions of the rat brain. Proc. R. Soc. B., 207, 1-12.
6. CAULFIELD, M.P. (1993). Muscarinic receptors-characterization, coupling and function. Pharmacol. Ther., 58, 319-379.
7. 50) of an enzymatic reactioin. Biochem. Pharmacol., 22, 3099-3108.
8. CLAGUE, R.U., EGLEN, R.M., STRACHAN, A.C. & WHITING, R.L. (1985). Action of agonists and antagonists at muscarinic receptor present on ileum and atria In Vitro Br. J. Pharmacol., 86, 163-170.
9. COYLE, J.T., PRICE, D.L. & DELONG, M.R. (1983). Alzheimer's disease: a disorder of cortical cholinergic innervation. Science, 219, 1184-1190.
10. 2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens. Eur. J. Pharmacol., 151, 205-221.
11. EMMELIN, N. & MUREN, A. (1951). Paralytic secretion in cats after treatment with atropine. Acta Physiol. Scand., 22, 277-280.
12. FREEDMAN, S.B., HARLEY, E.A. & IVERSEN, L.L. (1988). Reactive affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo-M ratio as an index of efficacy at cortical muscarinic receptors. Br. J. Pharmacol., 93, 437-445.
13. FRIEDMAN, M.J. & JAFFE, J.H. (1966). Changes in CNS sensitivity to cholinergic (muscarinic) agonists following withdrawal of chronically administered scopolamine. Pharmacologist, 8, 199.
14. HADDAD, E. & ROUSELL, J. (1998). Regulation of the expression and function of the muscarinic receptor. Trends Pharmacol. Sci., 19, 322-327.
15. KILBINGER, H., SCHNEIDER, R., SIEFKEN, H., WOLF, D. & D'AGOSTINO, G. (1991). Characterization of prejunctional muscarinic autoreceptors in the guinea-pig trachea. Br. J. Pharmacol., 103, 1757-1763.
16. MCPHERSON, G.A., MOLENAAR, P., RAPER, C. & MALTA, E. (1983). Analysis of dose-response curves and calculation of agonist dissociation constants using a weighted non-linear curve fitting program. J. Pharmacol. Methods, 10, 231-241.
17. NAGTEGAAL, J.E., SIERO, H.L.M., DIRKSEN, R., LAMMERS, J.-W.J., DE MIRANDA, R. & RUSSEL, F.G.M. (1995). Pancuronium masks the prejunctional muscarinic autoreceptor in guinea-pig tracheal smooth muscle. Life Sci., 57, 2325-2333.
18. NEWCOMB, R., TASHKIN, D.P., HUI, K.K. & CONOLLY, M.E. (1985). Rebound hyperresponsiveness to muscarinic stimulation after chronic therapy with an inhaled muscarinic antagonist. Am. Rev. Respir. Dis., 132, 12-15.
19. PALS-RYLAARSDAM, R., XU, R., WITT-ENDERBY, P., BENOVIC, J.L. & HOSEY, M.M. (1995). Desensitiszation and internalization of the m2 muscarinic acetylcholine receptor are directed by independent mechanisms. J. Biol. Chem., 270, 29004-29011.
20. PIERGENTILI, A., PIGINI, M., QUAGLIA, W., TAYEBATI, S.K., AMENTA, F., SABBATINI, M. & GIANNELLA, M. (1996a). Muscarinic thioligands with cyclopentane nucleus. Bioorg. Med. Chem., 4, 2193-2199.
21. PIERGENTILI, A., ANGELI, P., GIANNELLA, M., PIGINI, M., QUAGLIA, W. & TAYEBATI, S.K. (1996b). Bicyclic dioxolanes as potential antimuscarinic agent. Arzneim.-Forsch./Drug Res., 46, 99-105.
22. RINGDAHL, B. (1987). Selectivity of partial agonists related to Oxotremorine based on differences in muscarinic receptor reserve between the guinea-pig ileum and urinary bladder. Mol. Pharmacol., 31, 351-356.
23. ROUSELL, J., HADDAD, E.-B., MAK, J.C.W., WEBB, B.L.J., GIEMBYCZ, M.A. & BARNES, P.J. (1996). β-Adrenoceptor-mediated down-regulation of M2: muscarinic receptors: role of cyclic adenosine 5′-monophosphate-dependent protein kinase and protein kinase C. Mol. Pharmcol., 49, 629-635.
24. 3H]Oxotremorine (OXO) Binding to a mixture of M1 - M4 muscarinic receptors: use of NMS/ OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes. Neurochem. Res., 20, 669-674.
25. TAYEBATI, S.K., GIANNELLA, M., PIERGENTILI, A., PIGINI, M., QUAGLIA, W., SABBATINI, M. & AMENTA, F. (1997). Use of frozen sections for the pharmacological characterization of compounds active on neurotransmitter receptors. Clin. zExp. Hypertens., 19, 1023-1046.
26. VAN ROSSUM, J.M. (1963). Cumulative dose - response curves. II Technique for making dose-response curves in isolated organs and the evaluation of drug parameters. Arch. Int. Pharmacodyn. Ther., 143, 299-330.
27. VAN SCHAYCK, C.P., DOMPELING, E., VAN HERWAARDEN, C.L.A., FOLGERING, H., VERBEEK, A.L.M., VAN DER HOOGEN, H.J.M. & VANWEEL, C. (1991). Bronchodilator treatment in moderate asthma or chronic bronchitis: continuos or on demand? A randomised controlled study. Br. Med. J., 303, 1426-1431.
28. WALL, S.J., YASUDA, R.P. LIM, M., CISELA, W. & WOLFE, B.B. (1992). Differential regulation of subtypesd m1-m5 of muscarinic receptors in forebrain by chronic atropine administration. J. Pharmacol. Exp. Ther., 262, 584-588.
29. 2 recptor antagonist, on muscarinic and nicotinic cholinoceptors in guinea-pig airways in vivo and in vitro. Br. J. Pharmacol., 105, 107-112.
30. WITT-ENDERBY, P.A., YAMAMURA, H.I., HALONEN, M.L.A.I.J., PALMER, J.D. & BLOOM, J.W. (1995). Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment. Mol. Pharmacol., 47, 485-490.